Herrera-Hernández, C.;                     Segura-Diaz, A.;                     Stuckey, R.;                     López-RodrÃguez, J.F.;                     Gómez-Casares, M.T.    
        Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia. Hematol. Rep. 2025, 17, 47.
    https://doi.org/10.3390/hematolrep17050047
    AMA Style
    
                                Herrera-Hernández C,                                 Segura-Diaz A,                                 Stuckey R,                                 López-RodrÃguez JF,                                 Gómez-Casares MT.        
                Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia. Hematology Reports. 2025; 17(5):47.
        https://doi.org/10.3390/hematolrep17050047
    
    Chicago/Turabian Style
    
                                Herrera-Hernández, Carol,                                 Adrián Segura-Diaz,                                 Ruth Stuckey,                                 Juan Francisco López-RodrÃguez,                                 and MarÃa Teresa Gómez-Casares.        
                2025. "Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia" Hematology Reports 17, no. 5: 47.
        https://doi.org/10.3390/hematolrep17050047
    
    APA Style
    
                                Herrera-Hernández, C.,                                 Segura-Diaz, A.,                                 Stuckey, R.,                                 López-RodrÃguez, J. F.,                                 & Gómez-Casares, M. T.        
        
        (2025). Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia. Hematology Reports, 17(5), 47.
        https://doi.org/10.3390/hematolrep17050047